Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University

NCT07188467 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-10-09

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if an adapted version of Self-Help Plus (SH+), a stress management program developed by the World Health Organization, can reduce stress and improve well-being in international students at a U.S. university. The main questions it aims to answer are:

Does SH+ reduce perceived stress, anxiety, and depressive symptoms in international students? Does SH+ improve feelings of social support, self-efficacy, and adjustment in a new cultural environment?

Participants will:

Attend a two-day in-person workshop that includes animated videos, interactive activities, and group discussions.

Complete three surveys (before the workshop, right after, and six weeks later) about stress, mood, and well-being.

Optionally, take part in a short interview to share feedback about their experience.

Conditions

  • Stress, Psychological
  • Depression and/or Anxiety in the Mild-to-moderate Range
  • Loneliness
  • Adjustment, Psychological

Interventions

BEHAVIORAL

Digitized SH+

Digitized SH+ is a group-based, stress management program (adapted from the original Self-Help Plus intervention developed by the World Health Organization), that utilizes animated videos and group discussions to teach participants skills such as Grounding, Unhooking (from difficult thoughts), Being Kind (to self and others), Identifying Values, and Making Room for Difficult Thoughts and Feelings.

Sponsors & Collaborators

  • The New School

    lead OTHER

Principal Investigators

  • Adam D Brown, PhD · The New School, Center for Global Mental Health

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-07
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07188467 on ClinicalTrials.gov